Ironwood Pharmaceuticals (NASDAQ:IRWD – Get Free Report) was upgraded by equities researchers at StockNews.com from a “hold” rating to a “buy” rating in a research note issued to investors on Thursday ...

Reports Q4 revenue $$90.55M, consensus $93.85M. Reports LINZESS or Iinaclotide EUTRx prescription demand growth of 11% for full-year 2024 ...

Craig-Hallum analyst Chase Knickerbocker maintained a Buy rating on Ironwood Pharma (IRWD – Research Report) today. The company’s shares closed ...

Apraglutide in SBS Advancing Through Regulatory Submission and Review Ironwood is advancing apraglutide, a next-generation, synthetic glucagon-like peptide-2 (“GLP-2”) analog for short bowel ...

Q4 2024 Earnings Call Transcript February 27, 2025 Ironwood Pharmaceuticals, Inc. misses on earnings expectations. Reported ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

BOSTON (AP) — BOSTON (AP) — Ironwood Pharmaceuticals Inc. (IRWD) on Thursday reported fourth-quarter earnings of $3.2 million. On a per-share basis, the Boston-based company said it had profit of 2 ...

Glendale Ironwood made a frantic comeback in the final minutes with a suffocating defense and clutch baskets to beat Surprise Willow Canyon 59-56 on Thursday night in a packed gym. The two teams ...

A Saturday Women’s March in Ironwood started off with renditions of various songs, reworded to reference current events. The march, which was in honor of Women’s History Month, began at the Historic ...

BOSTON--(BUSINESS WIRE)--Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD), a biotechnology company developing and commercializing life-changing therapies for people living with gastrointestinal (GI ...

BOSTON (AP) — BOSTON (AP) — Ironwood Pharmaceuticals Inc. (IRWD) on Thursday reported fourth-quarter earnings of $3.2 million. On a per-share basis, the Boston-based company said it had profit ...